Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds NVIV.
No tracked institution reports a position in NVIV as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-04-27 | 1-for-25reverse |
| 2020-02-12 | 1-for-30reverse |
| 2018-04-17 | 1-for-25reverse |
| 2015-04-08 | 1-for-4reverse |
No one on the platform has traded NVIV yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| NVIVInVivo Therapeutics Holdings Corporation | $0.32 | -34.28% | $995918 | — |
| AXDXAccelerate Diagnostics, Inc. | $0.03 | +0.00% | $859918 | — |
| BLCMBellicum Pharmaceuticals, Inc. | $0.07 | -6.68% | $778326 | — |
| CWBRCohBar, Inc. | $0.41 | +0.00% | $1M | — |
| CYTOAltamira Therapeutics Ltd. | $0.30 | +100.00% | $1M | — |
| HTGMQHTG Molecular Diagnostics, Inc. | $0.00 | +0.00% | $221 | — |
| IMPLImpel Pharmaceuticals Inc. | $0.04 | -27.27% | $956000 | — |
Source: Financial Modeling Prep · peers by sector/industry